Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Organisation › Details

Bavarian Nordic (Group)

Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases, based on the Company’s live virus vaccine platform. Through long-standing collaborations, including a collaboration with the U.S. government, Bavarian Nordic has developed a portfolio of vaccines for infectious diseases, including the non-replicating smallpox vaccine, IMVAMUNE®, which is stockpiled for emergency use by the United States and other governments. The vaccine is approved in the European Union (under the trade name IMVANEX®) and in Canada. Bavarian Nordic and its partner Janssen are developing an Ebola vaccine regimen, which has been fast-tracked, with the backing of worldwide health authorities, and a vaccine for the prevention and treatment of HPV. Additionally, in collaboration with the National Cancer Institute, Bavarian Nordic has developed a portfolio of active cancer immunotherapies, including PROSTVAC®, which is currently in Phase 3 clinical development for the treatment of advanced prostate cancer. The company has partnered with Bristol-Myers Squibb for the potential commercialization of PROSTVAC. *

 

Period Start 1998-11-01 existent
Product Industry gene therapy
     
Region Region Denmark_oo
  Country Denmark
  Street 10A Hejreskovkovvej
  City 3490 Kvistgard
  Tel +45-3326-8383
    Address record changed: 2018-07-24
     
Basic data Employees D: 101 to 500 (2015-12-31)
  Currency DKK
  Annual sales 1,006,700,000 (revenue, consolidated (2016) 2016-12-31)
  Profit 30,600,000 (2016-12-31)
  Cash 854,000,000 (2016-12-31)
     
    * Document for �About Section�: Bavarian Nordic A/S. (3/7/16). "Press Release: Bavarian Nordic Announces Annual Report 2015". Copenhagen.
     
   
Record changed: 2018-10-30

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Bavarian Nordic (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top